[logo] HealthTree Foundation
search person

October 22, Myeloma Crowd Round Tables: Columbus, Ohio

Posted: Aug 26, 2016
October 22, Myeloma Crowd Round Tables: Columbus, Ohio image

Register Now myeloma crowd round tables Myeloma Crowd Round Tables are day-long meetings that provide patients and caregivers updated information so that they are able to make decisions about their treatment and care. Intended to go beyond "Myeloma 101" they help patients answer key questions: What should myeloma patients do at relapse? Or when they become refractory to treatments? Learn from top myeloma experts about relapsed and high-risk disease and what you can do to stay one step ahead for your best outcomes. This is a great opportunity to ask your questions and meet others in the myeloma community. Topics will include:

  • Diagnosing Low- and High-Risk Disease
  • Myeloma Genomics
  • Chromosomal Translocations and other High-Risk Features
  • Sequencing Effective Combination Therapies
  • Monoclonal Antibodies and Immunotherapy
  • Strategies for Refractory and Relapsed Patients
  • MGUS and Smoldering Myeloma Multi-Decade Study Review
  • Demystifying Clinical Trials
Date:

Saturday, October 22, 2016 Time: Registration begins at 8:00 am. Session runs from 9:00 am - 4:00 pm Site:

  •  The Fawcett Center at the Ohio State University, 2400 Olentangy River Road, Columbus, OH  43210
  • Hotels in the University Area: The Blackwell (614-247-4000), The Hilton Garden Inn (614-263-7200), Hyatt Place (614-280-1234), Spring Hill Suites (614-297-9912)
  • Closest airport is Port Columbus International Airport (CMH)
Cost:

 Registration is $25 per person. (Please contact info@crowdcare.org if you require additional financial assistance) Faculty:

  • Craig Hofmeister, MD, Ohio State University (Host)
  • Robert Kyle, MD, Mayo Clinic
  • Craig Emmitt Cole, MD, University of Michigan

     

Register Now myeloma crowd round tables Myeloma Crowd Round Tables are day-long meetings that provide patients and caregivers updated information so that they are able to make decisions about their treatment and care. Intended to go beyond "Myeloma 101" they help patients answer key questions: What should myeloma patients do at relapse? Or when they become refractory to treatments? Learn from top myeloma experts about relapsed and high-risk disease and what you can do to stay one step ahead for your best outcomes. This is a great opportunity to ask your questions and meet others in the myeloma community. Topics will include:

  • Diagnosing Low- and High-Risk Disease
  • Myeloma Genomics
  • Chromosomal Translocations and other High-Risk Features
  • Sequencing Effective Combination Therapies
  • Monoclonal Antibodies and Immunotherapy
  • Strategies for Refractory and Relapsed Patients
  • MGUS and Smoldering Myeloma Multi-Decade Study Review
  • Demystifying Clinical Trials
Date:

Saturday, October 22, 2016 Time: Registration begins at 8:00 am. Session runs from 9:00 am - 4:00 pm Site:

  •  The Fawcett Center at the Ohio State University, 2400 Olentangy River Road, Columbus, OH  43210
  • Hotels in the University Area: The Blackwell (614-247-4000), The Hilton Garden Inn (614-263-7200), Hyatt Place (614-280-1234), Spring Hill Suites (614-297-9912)
  • Closest airport is Port Columbus International Airport (CMH)
Cost:

 Registration is $25 per person. (Please contact info@crowdcare.org if you require additional financial assistance) Faculty:

  • Craig Hofmeister, MD, Ohio State University (Host)
  • Robert Kyle, MD, Mayo Clinic
  • Craig Emmitt Cole, MD, University of Michigan

     

The author Jennifer Ahlstrom

about the author
Jennifer Ahlstrom

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can contribute to cures by joining HealthTree Cure Hub and joining clinical research. Founder and CEO of HealthTree Foundation. 

Thanks to our sponsors:
Sanofi logo
Adaptive logo
Pfizer logo
GSK logo
newsletter icon

Get the Latest Multiple Myeloma Updates, Delivered to You.

By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.